Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Chronobiol Int. 2020 Mar 4;37(5):673–685. doi: 10.1080/07420528.2020.1732403

Table 2.

Multivariable-Adjusted Linear Regression Models for Associations of the MEQ score with CVH and CVD Risk Factors (N=506)*,

Overall Cardiovascular Health and Clinical CVD Risk Factors MEQ Score (continuous scale)
Beta p-value
AHA LS7 Total Score 0.02 (0.01) 0.014
Clinical CVD Risk Factors in AHA LS7
BMI (kg/m2) −0.02 (0.02) 0.453
Fasting Blood Glucose (mg/dL) −0.01 (0.08) 0.893
Systolic BP (mm Hg) −0.04 (0.06) 0.453
Diastolic BP (mmHg) −0.02 (0.05) 0.636
Total Cholesterol (mg/dL) 0.09 (0.16) 0.564
Clinical CVD Risk Factors Not Included in AHA LS7
Waist Circumference (inches) −0.03 (0.02) 0.145
LDL-C (mg/dL) 0.08 (0.14) 0.569
HDL-C (mg/dl) 0.04 (0.07) 0.600
Triglycerides (mg/dl) −0.16 (0.18) 0.372
Health Behaviors Not Included in AHA LS7
Sleep Duration (h/night) 0.01 (0.01) 0.148
PSQI −0.07 (0.02) <0.0001
ISI −0.14 (0.03) <0.0001
Sleep Onset Latency (min) −0.28 (0.14) 0.044
Sedentary Time (h/day) −0.11 (0.03) 0.001
*

AHA LS7: American Heart Association Life’s Simple 7; BMI: Body Mass Index; BP: Blood Pressure; HDL-C: High Density Lipoprotein Cholesterol; LDL-C: Low Density Lipoprotein Cholesterol; MEQ: Morningness-Eveningness score

All models were adjusted for age, race/ethnicity, education, health insurance, and menopausal status